课题基金 / 基金详情

DEPRESSION AND MORTALITY FOLLOWING MYOCARDIAL INFARCTION

DEPRESSION AND MORTALITY FOLLOWING MYOCARDIAL INFARCTION
心肌梗死后的抑郁和死亡率
批准号:
6183351
负责人:
ROBERT M CARNEY
金额:
$31.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 2003-04-30

项目摘要

项目成果

ROBERT M CARNEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Clinical depression is a powerful risk factor for mortality after an acute myocardial infarction (MI), yet little is known about the underlying mechanisms that account for this effect. The primary purpose of this study is to examine one of the most plausible candidate mechanisms, altered autonomic tone. Four hundred eighty post-MI patients with DSM-IV major or minor depression who are enrolled in the Usual Care arm of the NHLBI-sponsored ENRICHD (Enhancing Recovery in Coronary Heart Disease) clinical trial, and 480 non-depressed post-MI patients excluded from ENRICHD, will be recruited for this study during a two year period from four ENRICHD clinical centers. A 24 hour ambulatory ECG will be recorded after hospital discharge to obtain data on heart rate variability, myocardial ischemia, and ventricular arrhythmias. Patients will be followed up at 18 months, and psychosocial and medical endpoints, including mortality, will be ascertained. The primary analysis will determine whether heart rate variability accounts for the significantly higher mortality expected in the depressed compared to the non-depressed group, and whether this effect is largely concentrated in patients with ventricular arrhythmias and left ventricular dysfunction. The second purpose of the study is to identify clinical features or subtypes of depression that may be associated with a particularly high mortality risk and with altered autonomic tone, such as symptom severity, comorbid anxiety, or hostility. This mechanistic study will complement the clinical data to be obtained from the ENRICHD trial, and it would be considerably more costly and difficult to conduct a comparable study independently. Clarification of the underlying mechanism will greatly enhance the credibility of the epidemiological evidence that depression increases mortality in post-MI patients, and permit further refinements in risk stratification so that the patients at highest risk can be identified and treated the most aggressively.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fphys.2011.00065
发表时间: 2011
期刊: Frontiers in physiology
影响因子: 4
作者: [Hayano J, Kiyono K, Struzik ZR, Yamamoto Y, Watanabe E, Stein PK, Watkins LL, Blumenthal JA, Carney RM]
通讯作者: Carney RM
DOI: 10.1097/psy.0b013e3181835ca3
发表时间: 2008-09
期刊: Psychosomatic medicine
影响因子: 3.3
作者: [Carney RM, Steinmeyer B, Freedland KE, Blumenthal JA, Stein PK, Steinhoff WA, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Domitrovich PP, Burg MM, Hayano J, Jaffe AS]
通讯作者: Jaffe AS
DOI: 10.1097/psy.0b013e31826d2c81
发表时间: 2012-10
期刊: Psychosomatic medicine
影响因子: 3.3
作者: [Hayano J, Carney RM, Watanabe E, Kawai K, Kodama I, Stein PK, Watkins LL, Freedland KE, Blumenthal JA]
通讯作者: Blumenthal JA
DOI: 10.3389/fnins.2021.610955
发表时间: 2021
期刊: Frontiers in neuroscience
影响因子: 4.3
作者: [Hayano J, Ueda N, Kisohara M, Yuda E, Carney RM, Blumenthal JA]
通讯作者: Blumenthal JA
Fatigue, Anhedonia and Cardiac Prognostic Markers in Depressed Patients with Coronary Heart Disease
  • 批准号:
    10411951
  • 项目类别:
  • 资助金额:
    $73.61万
  • 财政年份:
    2020
  • 负责人:
    ROBERT M CARNEY
  • 依托单位:
Fatigue, Anhedonia and Cardiac Prognostic Markers in Depressed Patients with Coronary Heart Disease
  • 批准号:
    10171891
  • 项目类别:
  • 资助金额:
    $74.5万
  • 财政年份:
    2020
  • 负责人:
    ROBERT M CARNEY
  • 依托单位:
OMEGA-3 FOR DEPRESSION AND OTHER CARDIAC RISK FACTORS
  • 批准号:
    8988288
  • 项目类别:
  • 资助金额:
    $71.06万
  • 财政年份:
    2014
  • 负责人:
    ROBERT M CARNEY
  • 依托单位:
OMEGA-3 FOR DEPRESSION AND OTHER CARDIAC RISK FACTORS
  • 批准号:
    8787486
  • 项目类别:
  • 资助金额:
    $70.38万
  • 财政年份:
    2014
  • 负责人:
    ROBERT M CARNEY
  • 依托单位:
海外基金